Correspondence to Neuronal and Glial Metabolite Abnormalities in Participants with Persistent Neuropsychiatric Symptoms After COVID-19: A Brain Proton MRS Study.

Publication date: Jan 11, 2025

Open Access PDF

Concepts Keywords
Covid Abnormalities
Infect Brain
Neuropsychiatric Correspondence
Proton Covid
Glial
Infect
Metabolite
Mrs
Neuronal
Neuropsychiatric
Participants
Persistent
Proton
Study
Symptoms

Semantics

Type Source Name
disease MESH Abnormalities
disease MESH COVID-19
disease MESH Infectious Diseases
drug DRUGBANK L-Glutamine
drug DRUGBANK Glutamic Acid
drug DRUGBANK Benzylpenicillin
drug DRUGBANK Coenzyme M
pathway REACTOME Translation
disease IDO site
drug DRUGBANK gamma-Aminobutyric acid
drug DRUGBANK 1-naphthaleneacetic acid
drug DRUGBANK Inositol
disease MESH neuroinflammation
drug DRUGBANK Choline
drug DRUGBANK Iron
disease MESH oxidative damage
drug DRUGBANK Glutathione
drug DRUGBANK Taurine
drug DRUGBANK Isoxaflutole
disease MESH mitochondrial dysfunction
pathway REACTOME Metabolism
drug DRUGBANK Creatine
drug DRUGBANK Choline alfoscerate
disease MESH Inflammation
disease MESH Sequelae

Original Article

(Visited 1 times, 1 visits today)